Current Commercial Products
| Product | Description | Exclusives * |
|---|---|---|
| Adenine | Anticoagulant | End use |
| Benzyl benzoate | High purity excipient | None |
| Bretylium tosylate (US DMF) | Antiarrhythmic | USA |
| Chromic chloride | Trace element additive | None |
| Cupric sulfate | Trace element additive | None |
| Isoniazid (injectable grade only) | Tuberculosis | None |
| Manganese sulfate | Trace element additive | None |
| Selenious acid | Trace element additive | USA |
| Sodium molybdate | Trace element additive | None |
| Sodium iodide | Trace element additive | None |
| Thiamine hydrochloride (Vit B1) | Thiamine deficiency | None |
| Zinc sulfate | Zinc deficiency | None |
API Products Developed
| Product | Description | Exclusives * |
|---|---|---|
| Dapiprazole | Ophthalmic | None |
| Diphemanil methyl sulfate | Anticholinergic | None |
| Edaravone | Lou Gehrig's disease | None |
| Ethacrynic acid (US DMF) | Loop diuretic | None |
| Malathion (US DMF) | Head lice treatment | USA |
| Milrinone | Vasodilator | None |
| Pentamidine | Anti-infective | None |
| Piribedil | Antiparkinsonian | None |
| Tiopronin | Cystinuria | None |
| Tolcapone (US DMF) | Antiparkinsonian | USA |
| Sodium Thiosulfate (anhydrous or pentahydrate) (new) | Antidote - Cyanide poisoning, Cisplatin toxicity | None |
Excipients Developed
| Product | Description | Exclusives * |
|---|---|---|
| Benzyl alcohol (USP) (new) | High purity excipient | None |
| 2,4-Dichlorobenzyl alcohol | High purity excipient | None |
| Glycerol (USP) (new) | Excipient | None |
| Myristyl picolinium chloride | Preservative | None |
| Sucrose monolaurate | Excipient | None |
